Rossari Biotech (NSE:ROSSARI) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


NSE:ROSSARI Rossari Biotech Ltd NSE:ROSSARI
85 GF Score
Price ₹534.85
GF Value ₹998.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rossari Biotech Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Rossari Biotech's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

NSE:ROSSARI vs LIN, SHW, ECL: Margin of Safety % (DCF Earnings Based) Comparison

For the Specialty Chemicals subindustry, Rossari Biotech's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rossari Biotech Margin of Safety % (DCF Earnings Based) vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Rossari Biotech's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Rossari Biotech's Margin of Safety % (DCF Earnings Based) falls into.


NSE:ROSSARI
85GF Score
Rossari Biotech Ltd NSE:ROSSARI
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?

Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued. The current stock price of ₹534.85 is trading 46.4% below its estimated GF Value™ of ₹998.23. GuruFocus considers Rossari Biotech to be Possible Value Trap.

Key valuation signals for NSE:ROSSARI:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹998.23 vs. price of ₹534.85 (46.4% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rossari Biotech Business Description

Other Exchanges 543213:India
Address Rossari House, Lal Bahadur Shastri Marg, Golden Oak, Opp. Mahindra Showroom, Vikhroli (West), Surya Nagar, Mumbai, MH, IND, 400079
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score

Get the complete analysis for NSE:ROSSARI

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹534.85
Price
₹998.23
GF Value